Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Notes Payables (2013 - 2025)

Updated

Ernexa Therapeutics (ERNA) recorded Notes Payables of $2.25 million in Q1 2025.

Analysis

Ernexa Therapeutics (ERNA) Notes Payables (2013 - 2025) Analysis & Trends

At the end of FY2013, Ernexa Therapeutics reported Notes Payables of $631,000.

  • The Q1 2025 figure is the lowest quarterly Notes Payables since Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 2.25 Mn
Sep 30, 2014 1.82 Mn
Mar 31, 2014 702,000.00
Dec 31, 2013 631,000.00
API Access

Ernexa Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ERNA&period=max&api_key=YOUR_API_KEY